サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1462945

医薬品ファインケミカル市場：所有者タイプ別、化学品タイプ別、製品タイプ別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2024-2032年予測

Pharmaceutical Fine Chemicals Market, By Ownership Type, By Chemical, By Product Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 399 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.13円
医薬品ファインケミカル市場：所有者タイプ別、化学品タイプ別、製品タイプ別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2024-2032年予測
出版日: 2024年04月14日
発行: AnalystView Market Insights
ページ情報: 英文 399 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

医薬品ファインケミカル市場規模は2023年に1,323億2,200万米ドルとなり、2024年から2032年にかけてCAGR 7.8%で拡大

医薬品ファインケミカル市場-市場力学

高齢者人口の増加と消費者の健康意識の高まりが市場需要を促進

需要の増加が予想される背景には、高齢者人口の増加や消費者の健康意識の高まりなどがあります。ジェネリックの汎用化学品とは異なり、医薬品ファインケミカル（ファインケミカルとも呼ばれる）は、少量で高価格という特徴を持つ純粋な物質です。これらの純粋な化学物質は、基礎化学物質と組み合わされ、農業、医薬品、栄養補助食品などの分野にわたる多様な用途を持つ複雑な化合物を作り出します。医薬品ファインケミカルの製造は、米国FDAの規制を受ける原料にかかっています。この規制機関は、原料そのものと医薬品ファインケミカルから派生する製品の両方に品質基準を設けています。さらに、米国環境保護庁（EPA）は、これらの化学物質のための環境的に持続可能な工業施設の開発を奨励するガイドラインを発行し、生態学的責任と経済的実行可能性の両方を確保しています。世界的に、主要な業界関係者は研究開発イニシアチブに重点を置いています。特にアジア太平洋や中南米などの地域で新たなビジネスチャンスを生かすため、企業はこれらの市場での存在感を高めるために製造施設を設立しています。

医薬品ファインケミカル市場-主要インサイト

リサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約7.8%のCAGRで毎年成長すると予測されています。

市場セグメンテーションに基づくと、2023年には活性成分が最大の市場シェアを示すと予測されています。

製品タイプ別では、独占が2023年の主要タイプでした。

地域別では、北米が2023年に主要な収益源となりました。

医薬品ファインケミカル市場-セグメンテーション分析：

医薬品ファインケミカルの世界市場は、所有者タイプ、化学物質、製品タイプ、用途、地域に基づいてセグメント化されます。

市場は、所有タイプに基づいて2つのカテゴリに分かれています。独占と非独占です。2023年には、独占セグメントが最大の収益シェアを確保しました。特許で保護され、商品名を冠した独占の医薬品は、企業が利益を最大化するために追求しています。業界各社は、費用対効果と効能を両立させた医薬品を製造する技術を活用しています。医薬品ファインケミカルの大部分は、自社開発製品の基本構成要素となっています。

市場は製品タイプによって3つのカテゴリーに分けられます。基本構成要素、先端中間体、活性成分です。2023年に最も高い売上シェアを記録したのは活性成分です。企業は、顧客への合理的なサービスを確保するため、医薬品原薬（API）の世界製造施設を維持しています。顧客は高レベルの純度、品質、効力、真正性を要求するため、これらの分子は厳格な品質評価の下で生産されます。

医薬品ファインケミカル市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。

医薬品ファインケミカル市場-競合情勢：

医薬品ファインケミカルメーカーは、新製品開発、合弁事業、提携など、さまざまな戦略を採用しています。これらのアプローチは、市場への参入を拡大し、特定地域内のさまざまな最終用途における進化する技術的需要に対応することを目的としています。アジア太平洋地域の企業は、欧米の規制当局が課す厳しい規制監視のために後退に直面しています。同地域は労働コストや環境コストが低いという利点があるが、コストの上昇に伴い、こうした利点は徐々に失われつつあります。アジア太平洋地域には、欧米諸国と同等の製造能力を持つ小規模企業が数多く存在します。広範な流通チャネルが存在し、企業間の競争が激化しているため、予測期間中に新たなビジネスチャンスが生まれると予想されます。

目次

第1章 医薬品ファインケミカル市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 医薬品ファインケミカルの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 医薬品ファインケミカル産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 医薬品ファインケミカル市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 医薬品ファインケミカル市場情勢

  • 医薬品ファインケミカル市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 医薬品ファインケミカル市場- 所有形態別

  • 概要
    • セグメントシェア分析（所有権タイプ別）
    • 独占
    • 非独占的

第8章 医薬品ファインケミカル市場- 化学物質別

  • 概要
    • 化学物質別セグメントシェア分析
    • 小分子
    • 大きな分子

第9章 医薬品ファインケミカル市場-製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • 基本構成要素
    • 先端中間体
    • 活性成分

第10章 医薬品ファインケミカル市場- 用途別

  • 概要
    • 用途別セグメントシェア分析
    • 心臓血管
    • 神経学的
    • 腫瘍学
    • 感染症
    • 代謝システム
    • 糖尿病
    • 呼吸器
    • 胃腸
    • 粘膜骨格

第11章 医薬品ファインケミカル市場-地域

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析- 医薬品・ファインケミカル業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Denisco
    • Albemarle Corporation
    • Kenko Corporation
    • GRACE
    • CHEMADA
    • JMP Statistical Discovery LLC.
    • Pfizer Inc.
    • GSK plc
    • Others

第13章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Pharmaceutical Fine Chemicals Market: Ownership Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Ownership Type
  • TABLE Global Pharmaceutical Fine Chemicals Market, by Ownership Type 2019-2032 (USD Million)
  • TABLE Pharmaceutical Fine Chemicals Market: Chemical Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Chemical
  • TABLE Global Pharmaceutical Fine Chemicals Market, by Chemical 2019-2032 (USD Million)
  • TABLE Pharmaceutical Fine Chemicals Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Pharmaceutical Fine Chemicals Market, by Product Type 2019-2032 (USD Million)
  • TABLE Pharmaceutical Fine Chemicals Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Pharmaceutical Fine Chemicals Market, by Application 2019-2032 (USD Million)
  • TABLE Pharmaceutical Fine Chemicals Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Pharmaceutical Fine Chemicals Market, by Region 2019-2032 (USD Million)
  • TABLE North America Pharmaceutical Fine Chemicals Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Pharmaceutical Fine Chemicals Market, by Ownership Type, 2019-2032 (USD Million)
  • TABLE North America Pharmaceutical Fine Chemicals Market, by Chemical, 2019-2032 (USD Million)
  • TABLE North America Pharmaceutical Fine Chemicals Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Pharmaceutical Fine Chemicals Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Pharmaceutical Fine Chemicals Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Pharmaceutical Fine Chemicals Market, by Ownership Type, 2019-2032 (USD Million)
  • TABLE Europe Pharmaceutical Fine Chemicals Market, by Chemical, 2019-2032 (USD Million)
  • TABLE Europe Pharmaceutical Fine Chemicals Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Pharmaceutical Fine Chemicals Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Pharmaceutical Fine Chemicals Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Pharmaceutical Fine Chemicals Market, by Ownership Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Pharmaceutical Fine Chemicals Market, by Chemical, 2019-2032 (USD Million)
  • TABLE Asia Pacific Pharmaceutical Fine Chemicals Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Pharmaceutical Fine Chemicals Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Pharmaceutical Fine Chemicals Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Pharmaceutical Fine Chemicals Market, by Ownership Type, 2019-2032 (USD Million)
  • TABLE Latin America Pharmaceutical Fine Chemicals Market, by Chemical, 2019-2032 (USD Million)
  • TABLE Latin America Pharmaceutical Fine Chemicals Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Pharmaceutical Fine Chemicals Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Pharmaceutical Fine Chemicals Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Pharmaceutical Fine Chemicals Market, by Ownership Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Pharmaceutical Fine Chemicals Market, by Chemical, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Pharmaceutical Fine Chemicals Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Pharmaceutical Fine Chemicals Market, by Application, 2019-2032 (USD Million)
目次
Product Code: ANV2403

REPORT HIGHLIGHT

Pharmaceutical Fine Chemicals Market size was valued at USD 132,322 Million in 2023, expanding at a CAGR of 7.8% from 2024 to 2032.

Pharmaceutical fine chemicals, also recognized as active pharmaceutical ingredients (APIs), play a fundamental role in pharmaceutical formulations, dictating the therapeutic effects of drugs. These chemicals undergo rigorous purification processes to adhere to pharmaceutical standards of purity, potency, and safety. Encompassing a diverse array of compounds, including organic molecules, peptides, and biologics, pharmaceutical fine chemicals are synthesized through intricate chemical reactions and processes.

Pharmaceutical Market- Market Dynamics

Increasing elderly population and a growing awareness of health among consumers to propel market demand

The anticipated rise in demand is attributed to factors such as the increasing elderly population and a growing awareness of health among consumers. Unlike generic commodity chemicals, pharmaceutical fine chemicals, often referred to as fine chemicals, are pure substances characterized by their low volume and higher price structure. These pure chemicals are combined with foundational chemicals to create complex compounds with diverse applications across sectors such as agriculture, pharmaceuticals, and nutraceuticals. The manufacturing of pharmaceutical fine chemicals hinges on raw materials subject to regulation by the U.S. FDA. This regulatory body has set quality standards for both the raw materials themselves and the products derived from pharmaceutical fine chemicals. Additionally, the U.S. EPA has issued guidelines encouraging the development of environmentally sustainable industrial facilities for these chemicals, ensuring both ecological responsibility and economic viability. Globally, key industry players are directing their focus towards research and development initiatives. In order to capitalize on emerging opportunities, particularly in regions such as the Asia Pacific and Central & South America, companies are establishing manufacturing facilities to bolster their presence in these markets.

Pharmaceutical Fine Chemicals Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.8% over the forecast period (2024-2032)

Based on Ownership Type segmentation, active ingredients was predicted to show maximum market share in the year 2023

Based on Product Type segmentation, proprietary was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Pharmaceutical Fine Chemicals Market- Segmentation Analysis:

The Global Pharmaceutical Fine Chemicals Market is segmented on the basis of Ownership Type, Chemical, Product Type, Application, and Region.

The market is divided into two categories based on Ownership Type: Proprietary and Non Proprietary. In 2023, the proprietary segment secured the largest revenue share. Proprietary drugs, protected by patents and bearing a trade name, are pursued by companies to maximize their share of profits. Industry players are leveraging technologies to manufacture drugs that are both cost-effective and efficacious. A significant portion of pharmaceutical fine chemicals serves as fundamental building blocks for proprietary products.

The market is divided into three categories based on Product Type: Basic Building Blocks, Advanced Intermediates and Active Ingredients. The segment, active ingredients recorded the highest revenue share in 2023. Companies are upholding global manufacturing facilities for active pharmaceutical ingredients (APIs) to ensure streamlined services for their clientele. These molecules are produced under rigorous quality assessments, as customers demand high levels of purity, quality, potency, and authenticity.

Pharmaceutical Fine Chemicals Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Pharmaceutical Fine Chemicals Market- Competitive Landscape:

Pharmaceutical fine chemical manufacturers have embraced various strategies such as new product development, joint ventures, and collaborations. These approaches aim to expand market reach and address evolving technological demands across different end-use applications within specific regions. Enterprises in the Asia Pacific region have faced setbacks due to stringent regulatory scrutiny imposed by Western regulatory bodies. While the region benefits from lower labor and environmental costs, these advantages are gradually diminishing as costs rise. The Asia Pacific region is characterized by numerous small-scale players with manufacturing capabilities comparable to their Western counterparts. The presence of extensive distribution channels, coupled with heightened competition among players, is anticipated to create new opportunities over the forecast period.

Recent Developments:

In September 2022, IOL, announced plans to diversify into specialty chemicals and active pharmaceutical ingredients (APIs). This expansion initiative involves significant investments in establishing a production facility in western India. To secure authorization for selling APIs in regulated markets like Europe and the U.S., IOL intends to submit 4-5 drug master files (DMFs). The upcoming production facility is expected to play a pivotal role in streamlining this authorization process and further strengthening the company's industry presence.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT

Denisco

Albemarle Corporation

Kenko Corporation

GRACE

CHEMADA

JMP Statistical Discovery LLC.

Pfizer Inc.

GSK plc

Others

GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET, BY OWNERSHIP TYPE - MARKET ANALYSIS, 2019 - 2032

  • Proprietary
  • Non Proprietary

GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Basic Building Blocks
  • Advanced Intermediates
  • Active Ingredients

GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET, BY CHEMICAL- MARKET ANALYSIS, 2019 - 2032

  • Small Molecules
  • Big Molecules

GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Cardiovascular
  • Neurological
  • Oncological
  • Infectious Diseases
  • Metabolic System
  • Diabetes
  • Respiratory
  • Gastrointestinal
  • Mucoskeletal

GLOBAL PHARMACEUTICAL FINE CHEMICALS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Pharmaceutical Fine Chemicals Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Pharmaceutical Fine Chemicals Market Snippet by Ownership Type
    • 2.1.2.Pharmaceutical Fine Chemicals Market Snippet by Chemical
    • 2.1.3.Pharmaceutical Fine Chemicals Market Snippet by Product Type
    • 2.1.4.Pharmaceutical Fine Chemicals Market Snippet by Application
    • 2.1.5.Pharmaceutical Fine Chemicals Market Snippet by Country
    • 2.1.6.Pharmaceutical Fine Chemicals Market Snippet by Region
  • 2.2.Competitive Insights

3.Pharmaceutical Fine Chemicals Key Market Trends

  • 3.1.Pharmaceutical Fine Chemicals Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Pharmaceutical Fine Chemicals Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Pharmaceutical Fine Chemicals Market Opportunities
  • 3.4.Pharmaceutical Fine Chemicals Market Future Trends

4.Pharmaceutical Fine Chemicals Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Pharmaceutical Fine Chemicals Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Pharmaceutical Fine Chemicals Market Landscape

  • 6.1.Pharmaceutical Fine Chemicals Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Pharmaceutical Fine Chemicals Market - By Ownership Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Ownership Type, 2023 & 2032 (%)
    • 7.1.2.Proprietary
    • 7.1.3.Non Proprietary

8.Pharmaceutical Fine Chemicals Market - By Chemical

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Chemical, 2023 & 2032 (%)
    • 8.1.2.Small Molecules
    • 8.1.3.Big Molecules

9.Pharmaceutical Fine Chemicals Market - By Product Type

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 9.1.2.Basic Building Blocks
    • 9.1.3.Advanced Intermediates
    • 9.1.4.Active Ingredients

10.Pharmaceutical Fine Chemicals Market - By Application

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 10.1.2.Cardiovascular
    • 10.1.3.Neurological
    • 10.1.4.Oncological
    • 10.1.5.Infectious Diseases
    • 10.1.6.Metabolic System
    • 10.1.7.Diabetes
    • 10.1.8.Respiratory
    • 10.1.9.Gastrointestinal
    • 10.1.10.Mucoskeletal

11.Pharmaceutical Fine Chemicals Market- By Geography

  • 11.1.Introduction
    • 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2.North America
    • 11.2.1.Overview
    • 11.2.2.Pharmaceutical Fine Chemicals Key Manufacturers in North America
    • 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4.North America Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
    • 11.2.5.North America Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
    • 11.2.6.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.7.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.8.U.S.
      • 11.2.8.1.Overview
      • 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3.U.S. Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4.U.S. Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
      • 11.2.8.5.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.6.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.9.Canada
      • 11.2.9.1.Overview
      • 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3.Canada Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4.Canada Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
      • 11.2.9.5.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.6.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.3.Europe
    • 11.3.1.Overview
    • 11.3.2.Pharmaceutical Fine Chemicals Key Manufacturers in Europe
    • 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4.Europe Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
    • 11.3.5.Europe Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
    • 11.3.6.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.7.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.8.Germany
      • 11.3.8.1.Overview
      • 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3.Germany Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4.Germany Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
      • 11.3.8.5.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.6.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.9.Italy
      • 11.3.9.1.Overview
      • 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3.Italy Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4.Italy Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
      • 11.3.9.5.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.6.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.10.United Kingdom
      • 11.3.10.1.Overview
      • 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3.United Kingdom Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4.United Kingdom Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
      • 11.3.10.5.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.6.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.11.France
      • 11.3.11.1.Overview
      • 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3.France Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4.France Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
      • 11.3.11.5.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.6.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.12.Russia
      • 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2.Russia Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3.Russia Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
      • 11.3.12.4.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.13.Netherlands
      • 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2.Netherlands Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3.Netherlands Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
      • 11.3.13.4.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.14.Sweden
      • 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2.Sweden Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3.Sweden Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
      • 11.3.14.4.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.15.Poland
      • 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2.Poland Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3.Poland Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
      • 11.3.15.4.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.16.Rest of Europe
      • 11.3.16.1.Overview
      • 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3.Rest of the Europe Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4.Rest of the Europe Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
      • 11.3.16.5.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.6.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.4.Asia Pacific (APAC)
    • 11.4.1.Overview
    • 11.4.2.Pharmaceutical Fine Chemicals Key Manufacturers in Asia Pacific
    • 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4.Asia Pacific Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
    • 11.4.5.Asia Pacific Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
    • 11.4.6.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.7.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.8.India
      • 11.4.8.1.Overview
      • 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3.India Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4.India Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
      • 11.4.8.5.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.6.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.9.China
      • 11.4.9.1.Overview
      • 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3.China Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4.China Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
      • 11.4.9.5.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.6.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.10.Japan
      • 11.4.10.1.Overview
      • 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3.Japan Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4.Japan Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
      • 11.4.10.5.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.6.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.11.South Korea
      • 11.4.11.1.Overview
      • 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3.South Korea Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4.South Korea Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
      • 11.4.11.5.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.6.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.12.Australia
      • 11.4.12.1.Overview
      • 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3.Australia Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4.Australia Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
      • 11.4.12.5.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.6.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.13.Thailand
      • 11.4.13.1.Overview
      • 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3.Thailand Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4.Thailand Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
      • 11.4.13.5.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.6.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.14.Indonesia
      • 11.4.14.1.Overview
      • 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3.Indonesia Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4.Indonesia Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
      • 11.4.14.5.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.6.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.15.Philippines
      • 11.4.15.1.Overview
      • 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3.Philippines Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4.Philippines Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
      • 11.4.15.5.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.6.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.16.Rest of APAC
      • 11.4.16.1.Overview
      • 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3.Rest of APAC Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4.Rest of APAC Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
      • 11.4.16.5.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.6.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.5.Latin America
    • 11.5.1.Overview
    • 11.5.2.Pharmaceutical Fine Chemicals Key Manufacturers in Latin America
    • 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4.Latin America Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
    • 11.5.5.Latin America Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
    • 11.5.6.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.7.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.8.Brazil
      • 11.5.8.1.Overview
      • 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3.Brazil Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4.Brazil Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
      • 11.5.8.5.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.6.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.9.Mexico
      • 11.5.9.1.Overview
      • 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3.Mexico Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4.Mexico Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
      • 11.5.9.5.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.6.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.10.Argentina
      • 11.5.10.1.Overview
      • 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3.Argentina Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4.Argentina Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
      • 11.5.10.5.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.6.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.11.Colombia
      • 11.5.11.1.Overview
      • 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3.Colombia Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4.Colombia Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
      • 11.5.11.5.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.6.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.12.Rest of LATAM
      • 11.5.12.1.Overview
      • 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3.Rest of LATAM Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4.Rest of LATAM Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
      • 11.5.12.5.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.6.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.6.Middle East and Africa
    • 11.6.1.Overview
    • 11.6.2.Pharmaceutical Fine Chemicals Key Manufacturers in Middle East and Africa
    • 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4.Middle East and Africa Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
    • 11.6.5.Middle East and Africa Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
    • 11.6.6.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.7.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.8.Saudi Arabia
      • 11.6.8.1.Overview
      • 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3.Saudi Arabia Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4.Saudi Arabia Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
      • 11.6.8.5.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.6.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.9.United Arab Emirates
      • 11.6.9.1.Overview
      • 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3.United Arab Emirates Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4.United Arab Emirates Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
      • 11.6.9.5.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.6.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.10.Israel
      • 11.6.10.1.Overview
      • 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3.Israel Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4.Israel Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
      • 11.6.10.5.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.6.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.11.Turkey
      • 11.6.11.1.Overview
      • 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3.Turkey Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4.Turkey Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
      • 11.6.11.5.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.6.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.12.Algeria
      • 11.6.12.1.Overview
      • 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3.Algeria Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4.Algeria Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
      • 11.6.12.5.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.6.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.13.Egypt
      • 11.6.13.1.Overview
      • 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3.Egypt Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4.Egypt Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
      • 11.6.13.5.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.6.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.14.Rest of MEA
      • 11.6.14.1.Overview
      • 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3.Rest of MEA Market Size and Forecast, By Ownership Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4.Rest of MEA Market Size and Forecast, By Chemical, 2019 - 2032 (US$ Million)
      • 11.6.14.5.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.6.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Pharmaceutical Fine Chemicals Industry

  • 12.1.Competitive Dashboard
  • 12.2.Company Profiles
    • 12.2.1.Denisco
    • 12.2.2.Albemarle Corporation
    • 12.2.3.Kenko Corporation
    • 12.2.4.GRACE
    • 12.2.5.CHEMADA
    • 12.2.6.JMP Statistical Discovery LLC.
    • 12.2.7.Pfizer Inc.
    • 12.2.8.GSK plc
    • 12.2.9.Others

13.360 Degree Analyst View

14.Appendix

  • 14.1.Research Methodology
  • 14.2.References
  • 14.3.Abbreviations
  • 14.4.Disclaimer
  • 14.5.Contact Us